dc.contributor.advisor | Podder, Ashis Kumar | |
dc.contributor.author | Rahman, Imtiazur | |
dc.date.accessioned | 2018-04-12T04:33:05Z | |
dc.date.available | 2018-04-12T04:33:05Z | |
dc.date.copyright | 2018 | |
dc.date.issued | 2018-03 | |
dc.identifier.other | ID 13146002 | |
dc.identifier.uri | http://hdl.handle.net/10361/9855 | |
dc.description | This project report is submitted in partial fulfilment of the requirements for the degree of Bachelor of Pharmacy, 2018. | en_US |
dc.description | Catalogued from PDF version of project report. | |
dc.description | Includes bibliographical references (page 26-31). | |
dc.description.abstract | A great number of the world’s population suffers from the depressive disorder. Mental illness, depression, fear and stress-related illnesses are frequently treated with SSRI or selective serotonin reuptake inhibitor. Adverse effects like suicidal tendencies and mental breakdowns cannot be ignored along with beneficial effects of SSRIs. A thorough review and analysis of articles and documents published by relevant researchers and organizations were done to utilize information for every section of this project work. The review showed that the detrimental effects range from cardiac dysfunction to suicidal tendencies and violent behaviors. Depressive disorders if not treated, may result in more harmful circumstances. The review work also evaluated the superior therapeutic effects of SSRI drugs over other anti-depressants claimed by different researchers. Although it is not yet clear whether adverse effects like life-threatening behavior occurs due to SSRIs or not, doctors should make sure that depressive and nervous signs of illness are properly tested before prescribing SSRI medicine. Doctors and caregivers should also closely monitor potential adverse effects and changes in the patient’s behavior and personality during and after the treatment. | en_US |
dc.description.statementofresponsibility | Imtiazur Rahman | |
dc.format.extent | 32 pages | |
dc.language.iso | en | en_US |
dc.publisher | BRAC University | en_US |
dc.rights | BRAC University project reports are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. | |
dc.subject | SSRI | en_US |
dc.subject | Adverse effect | en_US |
dc.subject | Therapeutic effects | en_US |
dc.subject | Suicidal tendencies | en_US |
dc.subject | Discontinuation syndrome | en_US |
dc.title | Therapeutic and adverse effects of SSRIs | en_US |
dc.type | Project report | en_US |
dc.contributor.department | Department of Pharmacy, BRAC University | |
dc.description.degree | B. Pharmacy | |